Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant
Clinical trial NCT02862548 · COMPLETED
Trial details
- NCT number
- NCT02862548
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-16
- Primary completion
- 2018-02-08
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.